The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and Necroptosis, Pyroptosis, and PANoptosis
The Journal of Infectious Diseases · 29.05.2023 · 227 (11) · 1245-1254
DOI: 10.1093/infdis/jiad056 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 03.03.2023. Verfasst von Luca Schifanella und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Alveolar type II (ATII) pneumocytes as defenders of the alveolus are critical to repairing lung injury. We investigated the ATII reparative response in coronavirus disease 2019 (COVID-19) pneumonia, because the initial proliferation of ATII cells in this reparative process should provide large numbers of target cells to amplify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus production and cytopathological effects to compromise lung repair. We show that both infected and uninfected ATII cells succumb to tumor necrosis factor-α (TNF)-induced necroptosis, Bruton tyrosine kinase (BTK)-induced pyroptosis, and a new PANoptotic hybrid form of inflammatory cell death mediated by a PANoptosomal latticework that generates distinctive COVID-19 pathologies in contiguous ATII cells. Identifying TNF and BTK as the initiators of programmed cell death and SARS-CoV-2 cytopathic effects provides a rationale for early antiviral treatment combined with inhibitors of TNF and BTK to preserve ATII cell populations, reduce programmed cell death and associated hyperinflammation, and restore functioning alveoli in COVID-19 pneumonia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
- Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
- Department of Microbiology and Immunology, University of Minnesota, Minneapolis, Minnesota, USA.
- III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy.
- Department of Biomedical and Clinical Sciences, Università Degli Studi di Milano, Milan, Italy.
ORCID-Profile: Spinello Antinori, Mario Corbellino, Alessia Lai, Ashley T Haase
Förderung
- NIH HHS
- NIAID NIH HHS
- National Institutes of Health
- University of Minnesota
Zitieren
APA
Schifanella, L., Anderson, J., Wieking, G., Southern, P. J., Antinori, S., Galli, M., Corbellino, M., Lai, A., Klatt, N., Schacker, T. W., & Haase, A. T. (2023). The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and Necroptosis, Pyroptosis, and PANoptosis. The Journal of Infectious Diseases, 227(11), 1245-1254. https://doi.org/10.1093/infdis/jiad056
Vancouver
Schifanella L, Anderson J, Wieking G, Southern PJ, Antinori S, Galli M, et al. The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and Necroptosis, Pyroptosis, and PANoptosis. The Journal of Infectious Diseases. 2023;227(11):1245-1254. doi:10.1093/infdis/jiad056
BibTeX
@article{Schifanella2023,
author = {Schifanella, Luca and Anderson, Jodi and Wieking, Garritt and Southern, Peter J and Antinori, Spinello and Galli, Massimo and Corbellino, Mario and Lai, Alessia and Klatt, Nichole and Schacker, Timothy W and Haase, Ashley T},
title = {The Defenders of the Alveolus Succumb in COVID-19 Pneumonia to SARS-CoV-2 and Necroptosis, Pyroptosis, and PANoptosis},
journal = {The Journal of Infectious Diseases},
year = {2023},
volume = {227},
number = {11},
pages = {1245--1254},
doi = {10.1093/infdis/jiad056}
}
EUVIMED